Vascular endothelial growth factor (VEGF) is a well-known angiogenic factor in the eye, and is also a major pharmacological target for the treatment of severe and proliferative diabetic retinopathy (PDR) [3, 4]. This evidence concerns the gene VEGFA and proliferative diabetic retinopathy.